Toceranib

• Description :

  Toceranib phosphate is an orally active inhibitor of tyrosine kinase (RTK) receptor, and it potently inhibits PDGFR, VEGFR, and Kit (with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively), has antitumor and antiangiogenic activity.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  396.46

• Molecular Formula :

  C22H25FN4O2

• Notes :

  Research use only, not for human use.

• Receptor :

  PDGFR|VEGFR|Kit

• CAS Number :

  356068-94-5